Recombinant human holo-lactoferrin in complex with oleic acid suppresses the growth of solid myeloma more efficiently than its apo-form
Biochemistry and Cell Biology · 2025
DOI: 10.1139/bcb-2024-0159 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemistry and Cell Biology, 2025. Verfasst von A Yu Elizarova und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Experimental Medicine, Saint-Petersburg, Russia. Hauptthemen laut MEDLINE: Lactoferrin, Oleic Acid, Multiple Myeloma, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: State Assignment.
Abstract (Originalsprache)
Our previous study showed antitumor activity of the complex formed by iron-free recombinant human lactoferrin (apo-recHLF) and oleic acid (OA) (1:8 molar ratio) in a model of murine hepatoma 22a inoculated to C3HA mice. Taken alone, apo-recHLF was less efficient; i.e., the tumor growth index was 0.14 for recHLF-8OA and 0.63 for recHLF as compared with 1.0 in the control animals. In the present study, we evaluated antitumor activity of iron-saturated recHLF per se and of the complexes formed by OA with apo-recHLF and holo-recHLF. Balb/c mice with solid myeloma Sp2/0 were subjected to the 10-day treatment with daily intraperitoneal (i/p) injections of 10 mg iron-saturated recHLF with OA (1:8) per animal (0.4 g/kg). In 15 days, the tumor growth was substantially inhibited. Mean tumor mass was 93% lower as compared with the control value ( p < 0.01). I/p injections of apo-recHLF/OA complex did not inhibit the tumor growth. Holo-recHLF used without OA had less pronounced antitumor effect as compared with their complex.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute of Experimental Medicine, Saint-Petersburg, Russia.
- Saint-Petersburg State University, Saint-Petersburg, Russia.
- Scientific Practical Center of Animal Breeding, Zhodino, Belorussia.
ORCID-Profile: A V Sokolov, N P Gorbunov, V B Vasilyev
Förderung
- State Assignment
Zitieren
APA
Elizarova, A., Sokolov, A. V., Kostevich, V., Gorbunov, N., Kudryavtsev, I., Berson, Y., Yermalitsky, V., Budevich, A., & Vasilyev, V. (2025). Recombinant human holo-lactoferrin in complex with oleic acid suppresses the growth of solid myeloma more efficiently than its apo-form. Biochemistry and Cell Biology. https://doi.org/10.1139/bcb-2024-0159
Vancouver
Elizarova A, Sokolov AV, Kostevich V, Gorbunov N, Kudryavtsev I, Berson Y, et al. Recombinant human holo-lactoferrin in complex with oleic acid suppresses the growth of solid myeloma more efficiently than its apo-form. Biochemistry and Cell Biology. 2025. doi:10.1139/bcb-2024-0159
BibTeX
@article{Elizarova2025,
author = {Elizarova, A Yu and Sokolov, A V and Kostevich, V A and Gorbunov, N P and Kudryavtsev, I V and Berson, Yu M and Yermalitsky, V N and Budevich, A I and Vasilyev, V B},
title = {Recombinant human holo-lactoferrin in complex with oleic acid suppresses the growth of solid myeloma more efficiently than its apo-form},
journal = {Biochemistry and Cell Biology},
year = {2025},
doi = {10.1139/bcb-2024-0159}
}
EUVIMED